Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.70 | 15.93 |
| PEG Ratio (TTM) | -0.71 | 2.13 |
| P/S Ratio (TTM) | 0.58 | 1.68 |
| P/B Ratio (TTM) | 1.23 | 3.09 |
| P/FCF Ratio (TTM) | 5.01 | 11.15 |
| Price to 5YR AVG Earnings Ratio | -49.93 | 1.24 |
| Price to 5YR AVG FCF Ratio | 12.16 | 32.92 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.92% | 7.52% |
| ROE (TTM) | 18.87% | 17.66% |
| Net Profit Margin (TTM) | 8.70% | 9.27% |
| ROIC 5YR AVG | 18.83% | 6.25% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.82% | -174.15% | 398.47% |
| Revenue | 1.00% | -16.65% | -2.08% |
| Net Income | 50.69% | -175.19% | 405.48% |
| Cash Flow | 670.11% | 35.70% | 218.31% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.54 | 1.84 |
| Quick Ratio (TTM) | 1.66 | 1.32 |
| D/E Ratio (TTM) | N/A | 1.10 |
| Interest Coverage (TTM) | N/A | 16.52 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 3.28 | 2.92 |
| LTL to 5YR AVG FCF | 0.27 | 7.96 |
| Shares Outstanding Growth 5YR AVG | -0.10% | 6.67% |